Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Ford

Showing results (231-240 of 451) with videos related to

Pageof 46
Sort By:
Gut|April 4, 2020
Effect of ACE inhibitors and angiotensin II receptor blockers on disease outcomes in inflammatory bowel diseaseKeeley M Fairbrass, Deloar Hoshen, David J Gracie, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2025
Editorial: Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow-Up. Authors' ReplyChristy Riggott, Keeley M Fairbrass, David J Gracie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2015
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta-analysisEline J C A Kamp, John S Kane, Alexander C Ford
The Cochrane Database of Systematic Reviews|July 7, 2020
Helicobacter pylori eradication for the prevention of gastric neoplasiaAlexander C Ford, Yuhong Yuan, David Forman, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Dietary management of irritable bowel syndrome: considerations, challenges, and solutionsKevin Whelan, Alexander C Ford, Helen Burton-Murray, et al.
Neurogastroenterology and Motility|November 23, 2023
Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-upBrigida Barberio, Keeley M Fairbrass, David J Gracie, et al.
Gut|January 13, 2022
Efficacy of <i>Helicobacter pylori</i> eradication therapy for functional dyspepsia: updated systematic review and meta-analysisAlexander C Ford, Evangelos Tsipotis, Yuhong Yuan, et al.
Neurogastroenterology and Motility|September 17, 2021
Characteristics of, and natural history among, individuals with Rome IV functional bowel disordersVivek C Goodoory, Lesley A Houghton, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2022
Impact of Rome IV irritable bowel syndrome on work and activities of daily livingVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Neurogastroenterology and Motility|September 30, 2022
Willingness to pay for medications among patients with Rome IV Irritable Bowel SyndromeVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Pageof 46

Showing results (231-240 of 451) with videos related to

Sort By:
Pageof 46
Gut|April 4, 2020
Effect of ACE inhibitors and angiotensin II receptor blockers on disease outcomes in inflammatory bowel diseaseKeeley M Fairbrass, Deloar Hoshen, David J Gracie, et al.
Alimentary Pharmacology & Therapeutics|March 22, 2025
Editorial: Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow-Up. Authors' ReplyChristy Riggott, Keeley M Fairbrass, David J Gracie, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2015
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta-analysisEline J C A Kamp, John S Kane, Alexander C Ford
The Cochrane Database of Systematic Reviews|July 7, 2020
Helicobacter pylori eradication for the prevention of gastric neoplasiaAlexander C Ford, Yuhong Yuan, David Forman, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Dietary management of irritable bowel syndrome: considerations, challenges, and solutionsKevin Whelan, Alexander C Ford, Helen Burton-Murray, et al.
Neurogastroenterology and Motility|November 23, 2023
Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-upBrigida Barberio, Keeley M Fairbrass, David J Gracie, et al.
Gut|January 13, 2022
Efficacy of <i>Helicobacter pylori</i> eradication therapy for functional dyspepsia: updated systematic review and meta-analysisAlexander C Ford, Evangelos Tsipotis, Yuhong Yuan, et al.
Neurogastroenterology and Motility|September 17, 2021
Characteristics of, and natural history among, individuals with Rome IV functional bowel disordersVivek C Goodoory, Lesley A Houghton, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2022
Impact of Rome IV irritable bowel syndrome on work and activities of daily livingVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Neurogastroenterology and Motility|September 30, 2022
Willingness to pay for medications among patients with Rome IV Irritable Bowel SyndromeVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Pageof 46